FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

LOZUK ROBERT

2. Date of Event Requiring Statement (MM/DD/YYYY)
1/1/2016 

3. Issuer Name and Ticker or Trading Symbol

SEQUENOM INC [SQNM]

(Last)        (First)        (Middle)

3595 JOHN HOPKINS COURT

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
SVP, Commercial Ops /

(Street)

SAN DIEGO, CA 92121       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   23000   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Incentive Stock Option (right to buy)     (1) 1/31/2024   Common Stock   19000   $2.27   D    
Incentive Stock Option (right to buy)     (2) 6/16/2025   Common Stock   29000   $3.2   D    
Incentive Stock Option (right to buy)     (3) 2/9/2025   Common Stock   20000   $3.47   D    
Non-Qualified Stock Option     (4) 11/12/2022   Common Stock   125000   $3.99   D    
Restricted Stock Unit     (5)   (5) Common Stock   9000     (6) D    
Restricted Stock Unit     (7)   (7) Common Stock   16000     (8) D    
Restricted Stock Unit     (9)   (9) Common Stock   23000     (10) D    

Explanation of Responses:
( 1)  The shares subject to the options vest in 48 equal monthly installments commencing on 02/01/14, such that the shares subject to the option are fully vested on 02/01/18.
( 2)  The shares subject to the options shall vest in 48 equal monthly installments commencing on 06/17/15, such that the shares subject to the option are fully vested on 06/17/19.
( 3)  The shares subject to the options shall vest in 48 equal monthly installments commencing on 02/10/15, such that the shares subject to the option are fully vested on 02/10/19.
( 4)  The shares subject to the options vested 25% on 11/13/12, with the remainder vesting monthly over the next 36 months such that the option is fully vested on 11/13/16.
( 5)  The shares subject to the restricted stock unit shall vest in 4 equal annual installments commencing on 02/01/14, with annual vesting dates on 02/10/15, 02/10/16, 02/10/17, and 02/10/18 such that the shares subject to the restricted stock units are fully vested on 02/10/18.
( 6)  Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
( 7)  The shares subject to the restricted stock unit shall vest in 4 equal annual installments commencing on 02/10/15, with annual vesting dates on 02/10/16, 02/10/17, 02/10/18, and 02/10/19 such that the shares subject to the restricted stock units are fully vested on 02/10/19.
( 8)  Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
( 9)  The shares subject to the restricted stock unit shall vest in 4 equal annual installments commencing on 06/17/15, with annual vesting dates on 08/10/16, 08/10/17, 08/10/18, and 08/10/19 such that the shares subject to the restricted stock units are fully vested on 08/10/19.
( 10)  Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
LOZUK ROBERT
3595 JOHN HOPKINS COURT
SAN DIEGO, CA 92121


SVP, Commercial Ops

Signatures
Jeffrey D. Linton for Robert Lozuk 1/5/2016
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Sequenom, Inc. (NASDAQ:SQNM)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Sequenom, Inc. Charts.
Sequenom, Inc. (NASDAQ:SQNM)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Sequenom, Inc. Charts.